Revenue
2018
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $106.46B | $103.77B | $107.17B | $150.81B | $90.92B | $45.82B | $64.36B | $79.59B | $61.19B | $45.87B | $59.64B |
| Research & development | $352.0M | $348.0M | $311.0M | $308.0M | $291.0M | $254.0M | $300.0M | $315.0M | $307.0M | $298.0M | $344.0M |
| Operating expenses | $81.11B | $72.85B | $71.40B | $72.00B | $57.26B | $49.24B | $55.06B | $59.46B | $47.42B | $9.03B | $10.51B |
| Operating income | $25.35B | $30.93B | $35.77B | $78.81B | $33.66B | −$3.42B | $9.30B | $20.14B | $13.77B | $80.0M | $1.37B |
| EBITDAderived | $35.19B | $40.61B | $45.14B | $87.69B | $44.09B | $6.09B | — | — | — | — | — |
| Net income | $5.04B | $8.81B | $11.88B | $28.75B | $8.56B | −$5.51B | $1.84B | $7.54B | $4.59B | −$2.92B | −$5.19B |
| Basic EPSper diluted share | $1.94 | $3.12 | $3.93 | $9.06 | $2.64 | -$1.69 | $0.55 | $2.27 | $1.40 | -$0.91 | -$1.63 |
| Diluted EPSper diluted share | $1.94 | $3.11 | $3.93 | $9.03 | $2.63 | -$1.69 | $0.55 | $2.27 | $1.40 | -$0.91 | -$1.63 |